| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 87 | |
| #2 | United States | 75 | |
| #3 | WIPO (World Intellectual Property Organization) | 44 | |
| #4 | EPO (European Patent Office) | 38 | |
| #5 | Australia | 35 | |
| #6 | China | 26 | |
| #7 | Canada | 22 | |
| #8 | Japan | 13 | |
| #9 | Brazil | 10 | |
| #10 | Hong Kong | 10 | |
| #11 | Singapore | 10 | |
| #12 | Israel | 7 | |
| #13 | Taiwan | 6 | |
| #14 | Republic of Korea | 5 | |
| #15 | Argentina | 4 | |
| #16 | Hungary | 4 | |
| #17 | Chile | 3 | |
| #18 | Mexico | 3 | |
| #19 | Philippines | 3 | |
| #20 | Ukraine | 3 | |
| #21 | African Regional Industrial Property Organization | 2 | |
| #22 | Serbia | 2 | |
| #23 | Russian Federation | 2 | |
| #24 | South Africa | 2 | |
| #25 | Belgium | 1 | |
| #26 | Colombia | 1 | |
| #27 | EAPO (Eurasian Patent Organization) | 1 | |
| #28 | India | 1 | |
| #29 | Jordan | 1 | |
| #30 | Slovenia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement | |
| #5 | Foods and drinks | |
| #6 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Peptides | |
| #5 | Analysing materials | |
| #6 | Microorganisms | |
| #7 | Organic chemistry methods | |
| #8 | Acyclic or carbocyclic compounds | |
| #9 | Enzymes | |
| #10 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Congreve Miles Stuart | 182 |
| #2 | Brown Giles Albert | 163 |
| #3 | Tehan Benjamin Gerald | 160 |
| #4 | Pickworth Mark | 132 |
| #5 | Cansfield Julie Elaine | 70 |
| #6 | Christopher John Andrew | 53 |
| #7 | Mason Jonathan Stephen | 46 |
| #8 | Teobald Barry John | 44 |
| #9 | Tate Christopher Gordon | 40 |
| #10 | Weir Malcolm Peter | 39 |
| Publication | Filing date | Title |
|---|---|---|
| GB202103211D0 | Pharmaceutical compounds for use in therapy | |
| GB202020190D0 | Sars-Cov-2 MPRO inhibitor compounds | |
| GB202020191D0 | Pharmaceutical compounds | |
| GB202019667D0 | H4 antagonist comnpounds | |
| GB202016149D0 | Cyclic apelin receptor agonists | |
| GB202016152D0 | Linear Apelin Receptor Agonist | |
| GB202013558D0 | GRP52 Modularor compounds | |
| GB202011604D0 | GLP-1 receptor antagonists | |
| GB202005877D0 | H4 antagonist compounds | |
| GB202005858D0 | H4 Antagonist compounds | |
| GB202005552D0 | GPR35 agonist compounds | |
| GB202005550D0 | GPR35 agonist compounds | |
| GB202005546D0 | GPR35 Agonist compounds | |
| GB202005549D0 | GPR35 agonist compounds | |
| GB202003766D0 | Oral GLP receptor agonists | |
| GB202003762D0 | GLP receptor agonists | |
| GB202003764D0 | Oral GLP receptor agonists | |
| GB202003668D0 | GPR52 Modulator compounds | |
| GB201918974D0 | Gpr52 modulator compounds | |
| GB201918992D0 | GPR52 modulator compounds |